Test shown to improve accuracy in identifying precancerous pancreatic cysts

CompCyst, a new test, distinguishes pancreatic cysts that are destined to become cancer and need to be surgically removed from cysts that can be left alone without causing harm. The researchers believe CompCyst has the capacity to substantially reduce unnecessary surgeries for pancreatic cysts.